-
公开(公告)号:WO2020009522A1
公开(公告)日:2020-01-09
申请号:PCT/KR2019/008279
申请日:2019-07-05
Applicant: 일양약품주식회사
IPC: A61K31/506 , A61K9/00 , A61P25/00
Abstract: 본 발명은 라도티닙(Radotinib) 또는 그의 약제학적으로 허용 가능한 염을 유효성분으로 포함하는, 신경퇴행성 질환중의 하나인 프리온 질환의 예방 또는 치료를 위한 약제학적 조성물에 관한 것이다.
-
公开(公告)号:KR1020120118665A
公开(公告)日:2012-10-29
申请号:KR1020110036172
申请日:2011-04-19
Applicant: 일양약품주식회사
IPC: C07D413/06 , A61K31/496 , A61P31/16
CPC classification number: A61K31/496 , A61K31/42 , A61K31/454 , A61K45/06 , C07D261/08 , C07D261/18 , C07D413/06
Abstract: PURPOSE: A phenyl-isoxazole derivative and a method of manufacture thereof are provided to have influenza virus suppressing activity and to prevent the reproduction of the virus. CONSTITUTION: A phenyl-isoxazole derivative is represented by chemical formula 1. A manufacturing method of a compound of the chemical formula 1 comprises the following steps: manufacturing a compound of chemical formula 5 by reacting a compound of chemical formula 4 with hydroxylammoniumchloride under the presence of base; manufacturing a compound of chemical formula 7 which is isoxazol compound by using cyclization after manufacturing a compound of chemical formula 6 by using chloro reaction; and manufacturing a compound of chemical formula 9a or 9b by reacting with the compound of the chemical formula 2 or 3 after manufacturing a compound of chemical formula 8 by separating R10. The manufacturing method is processed under the presence of a tolerant solvent and/or acid or base.
Abstract translation: 目的:提供苯基异恶唑衍生物及其制备方法以具有流感病毒抑制活性并防止病毒繁殖。 构成:苯基 - 异恶唑衍生物由化学式1表示。化学式1的化合物的制备方法包括以下步骤:通过使化学式4的化合物与羟基氯化铵在存在下反应来制备化学式5的化合物 的基数 通过使用氯代反应制造化学式6的化合物后,通过使用环化制造化合物7的化合物的化合物,其为异恶唑化合物; 在制造化学式8的化合物之后,通过分离R10,与化学式2或3的化合物反应制备化学式9a或9b的化合物。 该制造方法在耐受溶剂和/或酸或碱的存在下进行处理。
-
公开(公告)号:KR1020120052095A
公开(公告)日:2012-05-23
申请号:KR1020100113560
申请日:2010-11-15
Applicant: 일양약품주식회사
IPC: C07D239/42 , A61K31/505 , A61P31/12
CPC classification number: Y02P20/55 , C07D239/42 , C07D401/04 , C07D403/04 , C07D417/04
Abstract: PURPOSE: An N-phenyl-2-pyrimidine isothiocyanate derivative compound is provided to suppress influenza virus and to prevent and treat viral infection. CONSTITUTION: An N-phenyl-2-pyrimidine isothiocyanate derivative compound is denoted by chemical formula 1. A method for preparing the compound of chemical formula 1 comprises: a step of reacting a compound of chemical formula 4a or 4b with a compound of chemical formula 5 to prepare a compound of chemical formula 6a or 6b; and a step of removing PG.
Abstract translation: 目的:提供N-苯基-2-嘧啶异硫氰酸酯衍生物化合物以抑制流感病毒并预防和治疗病毒感染。 构成:化学式1表示N-苯基-2-嘧啶异硫氰酸酯衍生物化合物。化学式1化合物的制备方法包括:使化学式4a或4b的化合物与化学式 以制备化学式6a或6b的化合物; 以及去除PG的步骤。
-
公开(公告)号:KR1020170009276A
公开(公告)日:2017-01-25
申请号:KR1020150101046
申请日:2015-07-16
Applicant: 일양약품주식회사
IPC: A61K31/506 , A61K31/497 , A61K31/4178
CPC classification number: A61K31/506 , A61K31/7056 , A61K38/21 , A61K45/06 , A61K2300/00
Abstract: 본발명은호흡기바이러스성질환치료를위한라도티닙(라도티닙)의새로운용도에관한것이다. 본발명에따르면화학식1 또는그의약학적으로허용되는염은코로나바이러스감염을예방, 개선및 치료하기위해사용할수 있다. 본발명은특히, 중동호흡기증후군코로나바이러스(MERS-CoV)의감염으로유발되는질병의예방및 치료에유용한항바이러스제로사용할수 있다.
Abstract translation: 本发明涉及化学式1化合物(radotinib)在预防或治疗病毒性呼吸道疾病中的新用途。 根据本发明,化学式1化合物或其药学上可接受的盐可用于预防,减轻或治疗冠状病毒感染。 具体地,本发明可以用作预防或治疗由中东呼吸综合征冠状病毒(MERS-CoV)感染引起的疾病的有用的抗病毒剂。
-
公开(公告)号:KR101369584B1
公开(公告)日:2014-03-06
申请号:KR1020110036172
申请日:2011-04-19
Applicant: 일양약품주식회사
IPC: C07D413/06 , A61K31/496 , A61P31/16
CPC classification number: A61K31/496 , A61K31/42 , A61K31/454 , A61K45/06 , C07D261/08 , C07D261/18 , C07D413/06
Abstract: 본 발병은 바이러스 감염 특히, 인플루엔자 바이러스를 치료하는 물질로서 유용한 하기 화학식 1의 페닐-이속사졸 유도체 화합물, 이의 약제학적으로 허용되는 유도체, 이의 제조방법, 및 이 화합물을 활성 성분으로 함유함을 특징으로 하는 질병 치료용 약제학적 조성물에 관한 것이다.
화학식 1
상기 식에서 R
1 , R
2 , R
3 , R
4 및 R
8 은 명세서에 정의된 바와 같다.
-
-
-
-